Literature DB >> 27733349

JAK inhibition in STING-associated interferonopathy.

Mathieu P Rodero1, Marie-Louise Frémond1, Gillian I Rice2, Bénédicte Neven3,4,5, Yanick J Crow1,2.   

Abstract

Keywords:  Disease Activity; Infections; Treatment

Mesh：

Substances：

Year:  2016        PMID： 27733349     DOI： 10.1136/annrheumdis-2016-210504

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  8 in total

Review 1.  [Familial chilblain lupus : Type 1 interferonopathy with model character].

Authors:  C Fiehn
Journal:  Z Rheumatol       Date:  2017-05       Impact factor: 1.372

2.  STING-Associated Vasculopathy with Onset in Infancy in Three Children with New Clinical Aspect and Unsatisfactory Therapeutic Responses to Tofacitinib.

Authors:  Xiaolei Tang; Hui Xu; Chunju Zhou; Yun Peng; Hui Liu; Jinrong Liu; Huimin Li; Haiming Yang; Shunying Zhao
Journal:  J Clin Immunol       Date:  2019-11-08       Impact factor: 8.542

Review 3.  Regulating STING in health and disease.

Authors:  Yang Li; Heather L Wilson; Endre Kiss-Toth
Journal:  J Inflamm (Lond)       Date:  2017-06-07       Impact factor: 4.981

Review 4.  JAK Inhibitors in Rheumatology: Implications for Paediatric Syndromes?

Authors:  S A Kerrigan; I B McInnes
Journal:  Curr Rheumatol Rep       Date:  2018-11-08       Impact factor: 4.592

Review 5.  IRF and STAT Transcription Factors - From Basic Biology to Roles in Infection, Protective Immunity, and Primary Immunodeficiencies.

Authors:  Trine H Mogensen
Journal:  Front Immunol       Date:  2019-01-08       Impact factor: 7.561

Review 6.  Mitochondrial Nucleic Acid as a Driver of Pathogenic Type I Interferon Induction in Mendelian Disease.

Authors:  Alice Lepelley; Timothy Wai; Yanick J Crow
Journal:  Front Immunol       Date:  2021-08-26       Impact factor: 7.561

Review 7.  The type I interferonopathies: 10 years on.

Authors:  Yanick J Crow; Daniel B Stetson
Journal:  Nat Rev Immunol       Date:  2021-10-20       Impact factor: 108.555

Review 8.  TMEM173 variants and potential importance to human biology and disease.

Authors:  Seema Patel; Lei Jin
Journal:  Genes Immun       Date:  2018-05-01       Impact factor: 2.676
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.